The anti-tumor effect of fibulin-5 is mediated through tumor microenvironment and suppression of MMP-7, which is overexpressed in NSCLC and associated with poor prognosis [29, 30]. This evidence concerns the gene MMP7 and non-small cell lung carcinoma.